← European Medicine Shortage Tracker · all medicines
Availability information only — Mobi Doctor doesn't sell medicines; check with a pharmacy.
Eplerenon currently has availability issues reported in 4 European registers: Austria, Spain, Italy, Sweden.
Shortage ATC C03DA04 · also listed as: EPLERENON · EPLERENONA · EPLERENONE · data refreshed 28 October 2026
As of 28 October 2026, 4 of the 10 tracked registers list current availability issues for Eplerenon, covering 8 affected product presentations. The longest-running open report was filed in Austria on 2022-12-14 and has now been open for about 46 months. Where agencies state a cause, unexpectedly high demand lead with 3 of the 4 stated-cause reports, followed by manufacturing problems with 1. The furthest expected-resolution date currently on file is 2026-12-31; the earliest is 2026-11-19. Notably, 1 report has already passed the expected-resolution date without closing — prognoses for this medicine should be read as estimates, not commitments. The issue spread across registers over time rather than at once: Austria reported first (2022-12-14), with Spain following roughly 46 months later — a pattern typical of supply problems cascading between national markets. Registers in Spain, Italy, Sweden indicate that alternatives or equivalents are available — a pharmacist or doctor can advise on switching. In the WHO ATC classification, Eplerenon is coded C03DA04 — a medicine acting on the cardiovascular system — so clinically related products appear under “Related medicines” below.
| Where | Status & products | Since | Expected end | Reason / alternatives | Source |
|---|---|---|---|---|---|
| 🇦🇹 Austria | Shortage Eplerenon ratiopharm GmbH 25 mg Filmtabletten (PZN 4211886) + 5 more productsEplerenon ratiopharm GmbH 25 mg Filmtabletten (PZN 4211892) Inspra 25 mg Filmtabletten (PZN 2461892) Inspra 25 mg Filmtabletten (PZN 2461900) Inspra 50 mg Filmtabletten (PZN 2461917) Inspra 50 mg Filmtabletten (PZN 2461923) | 2022-12-14 | 2026-12-31 | Verzögerung bei der Herstellung | register ↗ |
| 🇪🇸 Spain | Shortage EPLERENONA NORMON 50 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 30 comprimidos | 2026-10-12 | 2026-11-19 | Existen otros medicamentos con el mismo principio activo y misma vía. Alternatives: Existe/n otro/s medicamento/s con el mismo principio activo y para la misma vía de administración. | register ↗ |
| 🇮🇹 Italy | Shortage EPLERENONE ACCORD + 2 more productsEPLERENONE MYLAN EPLERENONE MYLAN | 2026-03-24 | — | Elevata richiesta Alternatives: AIFA: equivalents with the same active substance are available. | register ↗ |
| 🇸🇪 Sweden | Shortage Eplerenon Accord 25 mg Filmdragerad tablett | 2026-07-16 | 2026-09-30 | — Alternatives: Alternative(s) available — see the national register. | register ↗ |
Every individual register entry for Eplerenon in the tracked sources, newest first — including resolved and discontinued reports.
| Reg. | Product | Status | Reported | Expected end | Stated reason |
|---|---|---|---|---|---|
| 🇪🇸 ES | EPLERENONA NORMON 50 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 30 c | Shortage | 2026-10-12 | 2026-11-19 | Existen otros medicamentos con el mismo principio activo y m |
| 🇸🇪 SE | Eplerenon Accord 25 mg Filmdragerad tablett | Shortage | 2026-07-16 | 2026-09-30 | |
| 🇮🇹 IT | EPLERENONE MYLAN | Shortage | 2026-07-08 | — | Elevata richiesta |
| 🇮🇹 IT | EPLERENONE MYLAN | Shortage | 2026-06-25 | — | Elevata richiesta |
| 🇮🇹 IT | EPLERENONE ACCORD | Shortage | 2026-03-24 | — | Elevata richiesta |
| 🇦🇹 AT | Eplerenon ratiopharm GmbH 25 mg Filmtabletten (PZN 4211886) | Resolved | 2026-01-23 | — | Verzögerung bei der Herstellung |
| 🇦🇹 AT | Eplerenon ratiopharm GmbH 25 mg Filmtabletten (PZN 4211892) | Shortage | 2026-01-23 | — | Verzögerung bei der Herstellung |
| 🇦🇹 AT | Inspra 25 mg Filmtabletten (PZN 2461892) | Resolved | 2022-12-21 | 2025-11-28 | Erhöhter Mehrbedarf |
| 🇦🇹 AT | Inspra 25 mg Filmtabletten (PZN 2461900) | Shortage | 2022-12-21 | 2026-11-20 | Erhöhter Mehrbedarf |
| 🇦🇹 AT | Inspra 50 mg Filmtabletten (PZN 2461917) | Resolved | 2022-12-14 | 2025-11-28 | Erhöhter Mehrbedarf |
| 🇦🇹 AT | Inspra 50 mg Filmtabletten (PZN 2461923) | Limited availability | 2022-12-14 | 2026-12-31 | Erhöhter Mehrbedarf |
Yes. As of 28 October 2026, availability issues are reported in: Austria, Spain, Italy, Sweden. Availability is national — a shortage in one country does not mean it is short everywhere.
Agency prognoses on file range from 2026-11-19 to 2026-12-31. These are manufacturer-reported estimates and frequently move; check the linked register entry for the latest date.
5 of the active register entries indicate alternatives or equivalents (same active substance or an alternative treatment). Do not switch on your own — a pharmacist or prescriber can confirm the right substitute in your country.
Directly from the official medicines-agency registers that list Eplerenon: BASG (Austria), AEMPS CIMA (Spain), AIFA (Italy), Läkemedelsverket (Sweden). Every row on this page links to the underlying official record, and the dataset is refreshed from the primary sources every morning. Cross-language matching groups the same active substance across registers, so national spellings all resolve to this page.
Pharmacies, patient sites and newsrooms are welcome to embed the live status of Eplerenon — free, with attribution. Copy this snippet:
<iframe src="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/eplerenon/embed.html" width="100%" height="150" loading="lazy" style="border:1px solid #e1e0d9;border-radius:12px" title="Eplerenon availability in Europe"></iframe> <p style="font-size:12px">Source: <a href="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/eplerenon/">Eplerenon shortage status — European Medicine Shortage Tracker</a> by MobiDoctor</p>